Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

NCT00840801 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
302
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer